These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1786948)

  • 1. [Influences of new synthetic drug vesnarinone on circulatory and respiratory function of dogs].
    Zhou Z; Lan T; Zha Z; Wang Y; Yang Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Jun; 22(2):137-9. PubMed ID: 1786948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Chinese-made vesnarinone on experimental heart failure of dog].
    Du J; Yang Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Jun; 23(2):178-80. PubMed ID: 1452153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inotropic effect of novel cardiotonic agent, vesnarinone--tests on anaesthetized dogs].
    Han W; Wu Y; Zhang Z; Yang Z; Cai G
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Sep; 27(3):282-5. PubMed ID: 9389063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
    Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inotropic effect of novel domestic cardiotonic agent, vesnarinone--test in vitro].
    Han W; Qin Y; Zhang Z; Zhou S; Yang Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1994 Sep; 25(3):316-20. PubMed ID: 7896252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.
    Hashimoto K; Yabuuchi Y; Yamashita S; Mori T
    Arzneimittelforschung; 1984; 34(3A):390-3. PubMed ID: 6540094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of a new positive inotropic agent (OPC-8212) on intracellular potential of isolated canine ventricular papillary muscle].
    Zha Z; Lan T; Zhou Z; Yang Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1990 Jun; 21(2):159-62. PubMed ID: 2391096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OPC-18790, a novel positive inotropic agent, has both arterial and venous vascular dilating actions in the dog.
    Fujiki H; Mori T; Yoshida K; Imaizumi T; Tominaga M
    Eur J Pharmacol; 1996 Oct; 313(3):191-200. PubMed ID: 8911915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212), a new inotropic agent, on cardiotonic activity and coronary hemodynamics.
    Inoue M; Hori M; Nakajima S; Kitakaze M; Fukunami M; Ishida Y; Abe H
    Arzneimittelforschung; 1984; 34(3A):355-9. PubMed ID: 6540088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on tetradhydroisoquinolines (THI). II. Pharmacological action on the cardiovascular system.
    Sato M; Yamaguchi I; Kiyomoto A
    Jpn J Pharmacol; 1967 Jun; 17(2):153-63. PubMed ID: 5299980
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of carotid arterial and intravenous propofol administration for electrocerebral silence on circulation and respiration in dogs].
    Gai CL; Chen WM; Zheng XC; Ran DC; Ai CL; Sun ZQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1799-802. PubMed ID: 17259124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of vesnarinone on the myocardial force-length relationship in the in situ canine left ventricle].
    Nishiyama Y; Takeda K; Nakamura Y; Masuda T; Yagi S
    J Cardiol; 1994; 24(2):149-54. PubMed ID: 8164147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure.
    Matsumori A; Shioi T; Yamada T; Matsui S; Sasayama S
    Circulation; 1994 Mar; 89(3):955-8. PubMed ID: 8124835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of differentiation and enhancement of vincristine sensitivity of human erythroleukemia HEL cells by vesnarinone, a positive inotropic agent.
    Sato S; Tomoyasu S; Okabe-Kado J; Hozumi M; Tsuruoka N; Nakai S; Adachi M; Honma Y
    Exp Hematol; 1996 Jan; 24(1):37-42. PubMed ID: 8536790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart.
    Taira N; Endoh M; Iijima T; Satoh K; Yanagisawa T; Yamashita S; Maruyama M; Kawada M; Morita T; Wada Y
    Arzneimittelforschung; 1984; 34(3A):347-55. PubMed ID: 6331465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of OPC-18790, a new positive inotropic agent, on energetics in the ischaemic canine heart: a 31P-MRS study.
    Ishikawa M; Mori T; Itoh S; Fujiki H; Koga K; Tominaga M; Yabuuchi Y
    Cardiovasc Res; 1995 Aug; 30(2):299-306. PubMed ID: 7585818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of 1-(3,4-dimethoxyphenyl)-2-(4-diphenylmethylpiperazinyl) ethanol and possible mechanisms involved.
    Kushiku K; Ohba M; Araki T; Mikagi T; Katsuragi T; Furukawa T
    Arzneimittelforschung; 1989 Apr; 39(4):458-63. PubMed ID: 2751731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular properties of a new cardiotonic agent, MDL 19205.
    Dage RC; Roebel LE; Hsieh CP; Woodward JK
    J Cardiovasc Pharmacol; 1984; 6(1):35-42. PubMed ID: 6199609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.